RE:RE:RE:You Would Think Thatcrow27 wrote: I find it hard to believe that all the targets are in that $24-$26 range and you believe we will be range bound at the $17 - $18.
Do you not think that all these stock pickers would not tune into what you are saying if it was such a glaring problem. I mean they all have access to this information and if true why not just come out with much lower targets?
So far I have to admit that you have called the range correct.
Never said the top will be $18, if you check my earlier posts top of range would be close to the $24 convert price, around $16-$20. The only way around this is a big jump in EPS or tremendous momentem in buying like the weed stocks where debentures were converted to stock within a few months after issue when the share price was above the convert price. Go see how much dilution this caused to shareholder, ACB, HEXO as examples.
I wouldn't put any stock in some analyst or BNN expert's target prices. They are the ones that underwrite these securities so they put out positive targets. Furthermore you can't just look at a target price without looking at the EPS they expect. If it's above $24 clearly they are forecasting a big jump in earnings. Convertibles are a current shareholders worst enemy. Either we get diluted or we have to refinance them on possibly worse terms depending on market conditions.